Steris (STE) Cash & Equivalents (2017 - 2025)
Steris has reported Cash & Equivalents over the past 9 years, most recently at $423.7 million for Q4 2025.
- Quarterly results put Cash & Equivalents at $423.7 million for Q4 2025, up 173.04% from a year ago — trailing twelve months through Dec 2025 was $423.7 million (up 173.04% YoY), and the annual figure for FY2025 was $171.7 million, down 17.06%.
- Cash & Equivalents for Q4 2025 was $423.7 million at Steris, up from $319.2 million in the prior quarter.
- Over the last five years, Cash & Equivalents for STE hit a ceiling of $534.8 million in Q2 2021 and a floor of $155.2 million in Q4 2024.
- Median Cash & Equivalents over the past 5 years was $239.4 million (2021), compared with a mean of $271.7 million.
- Biggest five-year swings in Cash & Equivalents: tumbled 40.85% in 2022 and later skyrocketed 173.04% in 2025.
- Steris' Cash & Equivalents stood at $359.1 million in 2021, then decreased by 27.77% to $259.4 million in 2022, then decreased by 24.59% to $195.6 million in 2023, then decreased by 20.66% to $155.2 million in 2024, then soared by 173.04% to $423.7 million in 2025.
- The last three reported values for Cash & Equivalents were $423.7 million (Q4 2025), $319.2 million (Q3 2025), and $279.7 million (Q2 2025) per Business Quant data.